Home » Topics » BioWorld Science

BioWorld Science
RSS

KCC2 shows promise as therapeutic target for neonatal seizures

Nov. 29, 2021

Bristol Myers Squibb presents Gal-3 inhibitors

Nov. 29, 2021

Takeda Pharmaceutical identifies new 5-HT4 receptor agonists

Nov. 29, 2021

Merck & Co. synthesizes new LAAO inhibitors

Nov. 29, 2021

U.S. researchers patent TREM2 agonists

Nov. 29, 2021

Eli Lilly divulges new MRGPRX1 agonists

Nov. 29, 2021

Polycystic ovary syndrome murine model reveals CYP17 involvement

Nov. 26, 2021

ALD-2510 selectively depletes tumor-infiltrating Tregs for activity in vivo

Nov. 26, 2021

Osteoclasts modified with tetracycline show efficacy in models of heterotopic ossification

Nov. 26, 2021

Compounds targeting NPC1 protein show promising antiviral activity against SARS-CoV-2

Nov. 26, 2021

Popular Stories

Today's news in brief
BioWorld
BioWorld briefs for May 29, 2026.
TROP2 ADCs progress into first-line for lung, breast cancers
BioWorld
Multiple updates on TROP2-directed antibody-drug conjugates (ADCs) for lung and breast cancers highlight both progress made and opportunities for improvement for...
Researchers identify innate immune barrier against melanoma
BioWorld
Australian researchers have identified a previously overlooked population of immune cells in the skin that physically restrain melanoma growth by engulfing live...
Cavalon Therapeutics and Northwestern patent new Cav1.3 blockers
BioWorld Science
Cavalon Therapeutics Inc. and Northwestern University have disclosed new voltage-gated calcium channel Cav1.3 blockers potentially useful for the treatment of...
In the clinic for May 26, 2026
BioWorld
Clinical updates for biopharma and med tech, including data readouts and publications: 858, A2 Biotherapeutics, AC Immune, Agendia, Agenus, Aktis, Ascentage,...